Status:
COMPLETED
Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With Polyposis
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
American Rhinologic Society
Conditions:
Chronic Sinusitis
Polyposis
Eligibility:
All Genders
18-99 years
Phase:
PHASE3
Brief Summary
That high-dose steroid applied to the nasal cavity immediately post-operatively will improve olfaction and healing following endoscopic sinus surgery.
Eligibility Criteria
Inclusion
- hyposmia and nasal obstruction for \>12 weeks
- bilateral nasal polyposis
- candidate for surgery
Exclusion
- immunocompromised
- non-English speaking
- prisoner
- pregnant/lactating
- will not attend follow up appointments
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT01197612
Start Date
September 1 2010
End Date
June 1 2012
Last Update
May 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48103